| Product Name | Polyphyllin VI |
|---|---|
| CAS | 55916-51-3 |
| Formula | C39H62O13 |
| MW | 738.91 |
| Appearance | 白色粉末 |
| Boiling point | 871.2±65.0 °C | Condition: Press: 760 Torr |
| PKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Polyphyllin VI |
|---|---|
| CAS | 55916-51-3 |
| Formula | C39H62O13 |
| MW | 738.91 |
| Appearance | 白色粉末 |
| Boiling point | 871.2±65.0 °C | Condition: Press: 760 Torr |
| PKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000730
中文名稱：重樓皂苷VI
中文別名：重樓皂甙Ⅵ；重樓皂甙F；重樓皂苷Ⅵ；重樓皂苷D
英文名稱：Polyphyllin VI
英文別名：(3β,25R)-17-Hydroxyspirost-5-en-3-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;17-Hydroxyparis V;Paris VI;Paris saponin VI;Pennogenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside;Pennogenin-3-O-α-L-rhamnopyranosyl(1→2)-β-D-glucoside;Polygonatoside B3;Polyphyllin VI;Saponin Tb;
分子式：C39H62O13
分子量：738.90
CAS號：55916-51-3
純度：HPLC≥98%
沸點：871.2±65.0 °C | Condition: Press: 760 Torr
密度：1.38±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：12.85±0.70 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應客戶需求包裝
供應單位：四川省維克奇生物科技有限公司
供應電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產中藥類標準品和天然植物有效單體，主打中藥對照品/標準品/天然植物有效單體，化學合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
| Source:SCI：PHARMACOLOGICAL RESEARCH | Author:Min Xu | Notes：影響因子：4.816 |
| Reference description | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). | ||
